Cargando…
Review of preventative HIV vaccine clinical trials in South Africa
New HIV infections continue relentlessly in southern Africa, demonstrating the need for a vaccine to prevent HIV subtype C. In South Africa, the country with the highest number of new infections annually, HIV vaccine research has been ongoing since 2003 with collaborative public-private-philanthropi...
Autores principales: | Laher, Fatima, Bekker, Linda-Gail, Garrett, Nigel, Lazarus, Erica M., Gray, Glenda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426202/ https://www.ncbi.nlm.nih.gov/pubmed/32797338 http://dx.doi.org/10.1007/s00705-020-04777-2 |
Ejemplares similares
-
Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa
por: Lazarus, Erica Maxine, et al.
Publicado: (2014) -
Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial
por: Mpofu, Rephaim, et al.
Publicado: (2021) -
Hope for HIV control in southern Africa: The continued quest for a vaccine
por: Bekker, Linda-Gail, et al.
Publicado: (2017) -
Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa
por: Lazarus, Erica, et al.
Publicado: (2019) -
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
por: Malahleha, Mookho, et al.
Publicado: (2023)